Navigation Links
CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) today honored The Locking Cap as one of its "Top 5 Technologies To Reduce Prescription Drug Abuse."

This small safe is the only 4-digit combination locking cap for prescription bottles on the market to prevent prescription drug abuse among unauthorized users.

The Locking Cap's inventor Joseph Simpson began his crusade to stop prescription drug abuse in high school after witnessing his brother battle addiction. Now in college, Simpson and his team are dedicated to saving lives "one cap at a time."

"Our vision is to stop adolescent prescription abuse before it starts," said Simpson. "Along with being a deterrent, our product helps stop denial and start conversations between parents and kids."

The Top 5 Technologies competition aims to increase awareness of the prescription abuse epidemic, and support private-sector efforts addressing this problem.

CLAAD spokesman Michael Barnes stated, "The Locking Cap answers our organization's call for new products to foster safe medication storage and prevent kids from experimenting with prescription drugs."  

Millennium Laboratories co-sponsored the contest.  Millennium provides medication monitoring, detection and testing services.

"We are proud to recognize The Locking Cap for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Millennium Laboratories President Howard Appel. 

About the Center for Lawful Access and Abuse Deterrence

The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care.  CLAAD's National Prescription Drug Abuse Prevention Strategy, which has earned the endorsements of 30 non-profit organizations, identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition

About Millennium Laboratories

Millennium Laboratories (http://millenniumlabs.com/) is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About The Locking Cap

Prescription drug abuse is a serious public health problem that is rapidly becoming a global epidemic. The Locking Cap was created to protect families and prevent prescription drug abuse and overdoses. http://www.TheLockingCap.com, @The_Locking_Cap.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
2. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Warns of Increase in Prescription Drug Overdoses
5. MinuteClinic Recognizes National Nurse Practitioner Week and Invests in the Education and Advancement of Clinicians Across the U.S.
6. CareFusion Recognizes Best Of The Best U.S. Hospitals
7. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
8. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
9. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
10. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
11. Veteran-Owned Wiley X,® Inc. Recognizes Americas Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... 2017 , ... New patients from Charleston, SC, are now welcome to receive ... Pleasant, SC, with or without a referral. A full mouth reconstruction can transform the ... in Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw ...
(Date:5/23/2017)... ... May 23, 2017 , ... Patients in need of a ... practice to schedule an appointment, with or without a referral. Dr. Cotey is a ... to pediatric patients as a healthy alternative to a tooth extraction. , When a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... 22, 2017 , ... OSF Ventures, the corporate investment arm ... early stage company in San Francisco that has developed software to individualize treatment ... Fund acted as the lead investor in the round. , Medicine is ...
Breaking Medicine News(10 mins):